Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

338

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Major Depressive Disorder
Interventions
DRUG

Quetiapine

Trial Locations (43)

Unknown

Research Site, Birmingham

Research Site, San Diego

Research Site, Fort Myers

Research Site, Gainsville

Research Site, Sarasota

Research Site, Roswell

Research Site, Boston

Research Site, Brooklyn

Research Site, Eugene

Research Site, Jenkintown

Research Site, Memphis

Research Site, Austin

Research Site, San Antonio

Research Site, City Bell

Research Site, La Plata

Research Site, Córdoba

Research Site, Mendoza

Research Site, Buenos Aires

Research Site, Capital Federal

Research Site, Tartu

Research Site, Tallinn

Research Site, Viljandi

Research Site, Helsinki

Research Site, Tampere

Research Site, Järvenpää

Research Site, Kuopio

Research Site, Salo

Research Site, Seinäjoki

Research Site, Arkhangelsk

Research Site, Izhevsk

Research Site, Lipetsk

Research Site, Moscow

Research Site, Nizhny Novgorod

Research Site, Perm

Research Site, Saint Petersburg

Research Site, Stavropol

Research Site, Hlevakha

Research Site, Dnipropetrovsk

Research Site, Donetsk

Research Site, Kiev

Research Site, Luhansk

Research Site, Odesa

Research Site, Vinnitsa

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY